In the biopharmaceutical industry, the strategic implementation of Generative AI is becoming a critical lever for value creation. We have delineated over 50 actionable use cases across Commercial, R&D/Clinical, and Supply Chain/Manufacturing sectors, which are poised for swift execution to unlock tangible benefits.
- Risk Mitigation: We prioritize use cases with lower risk profiles to ensure safety, compliance, and reputational integrity remain uncompromized.
- Business Value Maximization: We evaluated use cases that could deliver transformational change at a score of 6 or above, significant optimizations use cases scored between 3 to 5, and those offering modest improvements, as per current Gen AI capabilities, scored below 3.
- Effort Optimization: We advocate for use cases that harness existing foundational models with minimal adaptation. Our framework categorizes High effort at a score of 10 (approximately 8+ weeks of effort), Medium effort at a score of 5 (4-8 weeks of effort), and Low effort is tagged as 1 (under 4 weeks of effort). For effort, we considered a lean operational teams of 5 FTE.
It is imperative to recognize that the efficacy of these use cases is contingent upon the integrity of underlying data. Initiatives to purify data through LLMs and to fortify data governance are not just preparatory steps; they are foundational to the successful activation of Generative AI capabilities within the organization.
- Commercial
- R&D / Clinical
- Supply / Manufacturing
- More
Fast Track to Value with Generative AI
Unlock the secrets to successful business transformation with Gen AI – We will soon publish our essential guide, tailored to help organizations navigate their journey to innovation and success.